AP-101
AP-101 is a medicine that is designed to help people with a type of cancer called Acute Myeloid Leukemia (AML). AML is a disease where there are too many bad cells in the bone marrow, which is a part of our body where blood cells are made. AP-101 is made up of really tiny pieces called molecules, and these molecules can stick to certain parts of the AML cells to stop them from growing and spreading.
When someone with AML takes AP-101, the medicine travels through their body and finds the AML cells. When it gets there, the medicine molecules stick to the bad AML cells like glue, and this stops them from growing out of control. This makes the bad AML cells weaker and easier for the body to kill.
AP-101 is a type of medicine called an investigational drug, which means scientists and doctors are still testing it to make sure it is safe and effective. They are doing careful studies to make sure it works well and doesn't cause any bad side effects. If the studies go well, AP-101 might be approved by the government so doctors can use it to help people with AML.
When someone with AML takes AP-101, the medicine travels through their body and finds the AML cells. When it gets there, the medicine molecules stick to the bad AML cells like glue, and this stops them from growing out of control. This makes the bad AML cells weaker and easier for the body to kill.
AP-101 is a type of medicine called an investigational drug, which means scientists and doctors are still testing it to make sure it is safe and effective. They are doing careful studies to make sure it works well and doesn't cause any bad side effects. If the studies go well, AP-101 might be approved by the government so doctors can use it to help people with AML.